Related Experiment Video
Updated: Jun 29, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease
Derek Leong1, Benita Tjoe1, Parham Zarrini1
1Barbra Streisand Women's Heart Center, Cedars-Sinai Smidt Heart Institute, Los Angeles, CA, United States of America.
Insights
Women with ischemia and no obstructive coronary artery disease (INOCA) face higher heart failure (HF) risks. Novel predictors include high IL-6, low coronary flow reserve, and poor functional status, aiding future prevention strategies.
Area of Science:
- Cardiology
- Women's Health
- Heart Failure Research
Background:
- Women with ischemia and no obstructive coronary artery disease (INOCA) have increased risk for heart failure (HF) hospitalizations, primarily HF with preserved ejection fraction (HFpEF).
- Identifying predictors for HF development in this population is crucial for targeted interventions.
Purpose of the Study:
- To identify predictors for heart failure (HF) development in women with ischemia and no obstructive coronary artery disease (INOCA).
- To analyze long-term prospective follow-up data from a deeply phenotyped cohort of women with INOCA.
Main Methods:
- Utilized data from 493 women in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
- Employed multivariate Cox analysis to assess associations between baseline characteristics and HF hospitalizations.
- Considered clinical history, medications, physical exam, laboratory data, and angiographic data, including coronary flow reserve (CFR).
Main Results:
- During a median 6-year follow-up, 3.7% of women were hospitalized for HF.
- Diabetes mellitus and tobacco use were associated with HF hospitalization.
- Novel predictors identified included higher resting heart rate, multi-parity, elevated IL-6 levels, lower CFR, and poor functional status, independent of traditional HFpEF risk factors.
Conclusions:
- Women with INOCA have a considerable incidence of long-term HF hospitalization.
- Novel risk factors such as multi-parity, high IL-6, low CFR, and poor functional status independently predict HF hospitalization.
- These findings may inform mechanistic understanding and future treatment targets for preventing HFpEF in women.
Study Objective:
Women with ischemia and no obstructive coronary artery disease (INOCA) are at increased risk for heart failure (HF) hospitalizations, which is predominantly HF with preserved ejection fraction (HFpEF). We aimed to identify predictors for the development of heart failure HF in a deeply phenotyped cohort of women with INOCA and long-term prospective follow-up.
Design Setting And Participants:
Women enrolled in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) were evaluated for baseline characteristics including clinical history, medications, physical exam, laboratory data and angiographic data. Using a multivariate Cox analysis, we assessed the association between baseline characteristics and the occurrence of HF hospitalizations in 493 women with evidence of ischemia but no obstructive coronary disease, no prior history of HF, and available follow-up data.
Results:
During a median follow-up of 6-years, 18 (3.7%) women were hospitalized for HF. Diabetes mellitus and tobacco use were associated with HF hospitalization. In a multivariate analysis adjusting for known HFpEF predictors including age, diabetes, hypertension, tobacco use, and statin use, novel predictive variables included higher resting heart rate, parity and IL-6 levels and lower coronary flow reserve (CFR) and poor functional status.
Conclusions:
There is a considerable incidence of HF hospitalization at longer term follow-up in women with INOCA. In addition to traditional risk factors, novel risk variables that independently predict HF hospitalization include multi-parity, high IL-6, low CFR, and poor functional status. These novel risk factors may be useful to understand mechanistic pathways and future treatment targets for prevention of HFpEF.
More Related Videos
05:07Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice
Published on: August 25, 2023
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pathophysiology of Heart Failure
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Factors Influencing Heart Rate
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
Heart Failure Drugs: Diuretics